MYOV

MYOV Stock Pops as Sumitomo Agrees to Buy Myovant Sciences

By David Moadel, InvestorPlace Contributor
Acquisition announcements can cause explosive share-price moves, and MYOV stock is spiking in the wake of a big-dollar buyout announcement.

Why Is Myovant Sciences (MYOV) Stock Up 30% Today?

By Joel Baglole, InvestorPlace Contributor
The prospect that shareholders could get 27% or more to tender their shares has MYOV stock up sharply today.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

3 Biotech Stocks Ready for Big Breakthroughs Like Biogen

By Muslim Farooque, InvestorPlace Contributor
This could be a breakthrough year for these three biotech stocks, resulting in massive gains for their stockholders similar to Biogen.

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

By Louis Navellier and the InvestorPlace Research Staff
The pandemic has raised awareness about the value of biotech across the world. In turn, these biotech stocks will benefit down the road.